{"id":"cargutocin","rwe":[],"tags":[{"label":"cargutocin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"statocin","offLabel":[],"synonyms":["cargutocin","statocin","Y 5330"],"timeline":[],"brandName":"Statocin","ecosystem":[],"mechanism":{"modality":"Peptide","drugClass":"cargutocin","explanation":"Imagine your body's cells have locks on them, and Statocin is a key that fits into those locks. When it binds, it can either block or enhance the activity of the cell, depending on the lock it's interacting with. This interaction can lead to changes in how the cell behaves, which can be beneficial in treating certain conditions.","oneSentence":"Statocin works by binding to a specific target, although the exact target is unknown.","technicalDetail":"Statocin's mechanism of action is not well understood, but it is believed to involve binding to a specific protein or receptor, potentially altering downstream signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3069","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARGUTOCIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:10:43.992325","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:50:39.336482+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"genericName":"cargutocin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"1RJ33Z503O","CHEBI":"CHEBI:135895","INN_ID":"3986","UMLSCUI":"C0604369","ChEMBL_ID":"CHEMBL2218869","KEGG_DRUG":"D09797","PUBCHEM_CID":"20057048"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Recombinant protein","firstApprovalDate":"","aiSummary":"Statocin, also known as Cargutocin, is a small molecule drug of the cargutocin class. Unfortunately, there is limited information available on this drug, including its target, approved indications, and commercial status. As a result, it is difficult to provide a comprehensive summary of its use and safety profile. Further research is needed to determine the efficacy and safety of Statocin in clinical settings. Without more information, it is challenging to assess its potential as a treatment option.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:50:39.336482+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}